What Are Best Practices When Changing From One eClinical Vendor To Another?
Choose A Vendor With Proven Experience And Solutions
In this case study example, an emerging biopharmaceutical company determine it needed to change vendors in order to meet study milestones and get more robust technical capabilities from EDC and RTSM systems to support the protocol. Signant Biotech proved that its Unified Platform was up to the task and that it had clinical science and operational resources to support the transition and the needs of the Phase III CNS trial.
Develop A Migration Plan
Working in conjunction with a dedicated project team at Signant Biotech, the sponsor developed a plan to migrate study designs and data from the former systems. Within four weeks, the migration was complete and the implementation met all specifications and requirements.
Leverage Existing Groundwork
The teams were able to meet deadlines without delays, errors, or missing data by taking advantage of existing templates, designs, library templates, as well as a unified CDISC ODM database. Overseen by detail-oriented project teams, data migrations were implemented seamlessly, and the model was used for subsequent studies.
Learn more in this case study.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.